Pharnext: phase III study data frozen -December 04, 2023 at 06:36 am EST

On Monday, Pharnext announced the freezing of data from its pivotal Phase III study in Charcot Marie-Tooth disease type 1A, the last step before publication of the clinical trial results.Verification...

Related Keywords

Charcot Marie , ,Charcot Marie Tooth ,Markets ,